Medical Properties Trust Inc
NYSE: MPW · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-01-30
Medical Properties Trust Inc (MPW) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for MPW.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
MPW historical valuation range
Where current P/E sits in MPW's own 5Y range.
MPW intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
MPW valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 2.99x
Is MPW overvalued in 2026?
Medical Properties Trust Inc (MPW) currently trades at $5.02 per share with a market capitalization of $3,019,530,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 51/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
MPW currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 3.0x, the market is valuing the company primarily on its revenue rather than its earnings.
A standard DCF model does not produce reliable output for MPW under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: MPW trades at a fair valuation on our framework, with a Smart Value Score of 51/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is MPW overvalued in 2026?
Based on a Smart Value Score of 51/100, MPW is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is MPW's fair value?
Standard DCF is unreliable for MPW due to its current profitability profile. Revenue-based approaches such as EV/Sales or historical P/S percentile are more informative for this stock.
What P/E ratio does MPW trade at?
MPW does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is MPW a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 51/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does MPW's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on MPW.
What is MPW's Smart Value Score?
MPW's Smart Value Score is 51/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.